Effects of SM-9018, a novel 5-HT2 and D2 receptor antagonist, on electrically-evoked [3H]acetylcholine release from rat striatal slices

General Pharmacology

Volumn 27, Issue 7, 1996, Pages 1203-1207

  Ishida, Kumiko ^a   Ohno, Yukihiro ^a   Ishibashi, Tadashi ^a   Nakamura, Mitsutaka ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

5 HT2 receptors; 3H ACh release; D2 receptors; in vitro superfusion; neuroleptics; SM 9018; striatal slices

Indexed keywords

1 ISOPROPYL 6 METHYLERGOLINE 8 CARBOXYLIC ACID 2 HYDROXY 1 METHYLPROPYL ESTER; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ACETYLCHOLINE; CALCIUM ION; CHLORPROMAZINE; CHOLINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; EMONAPRIDE; HALOPERIDOL; HEMICHOLINIUM 3; NEUROLEPTIC AGENT; NEW DRUG; PEROSPIRONE; QUINPIROLE; RADIOISOTOPE; RESERPINE; SEROTONIN 2 ANTAGONIST; SEROTONIN 2 RECEPTOR; SPIPERONE; TETRODOTOXIN;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG ANTAGONISM; DRUG POTENCY; ELECTROSTIMULATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ANIMALS; ANTIPSYCHOTIC AGENTS; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; ELECTRIC STIMULATION; HALOPERIDOL; INDOLES; MALE; NEOSTRIATUM; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; SEROTONIN ANTAGONISTS; THIAZOLES;

EID: 0030273513     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00056-0     Document Type: Article

References (25)

1. 3H]acetylcholine in rat striatal slices: an experimental model for drugs that enhance dopaminergic neurotransmission. J. Neurochem. 44, 331-317.
2. Bertorelli R. and Consolo S. (1990) D1 and D2 dopaminergic regulation of acetylcholine release from striata of freely moving rats. J. Neurochem. 54, 2145-2148.
3. 2 receptor antagonists. J. Pharmacol. Exp. Ther. 235, 319-325.
4. Cubeddu L. X. and Hoffmann I. S. (1985) Frequency-dependent release of acetylcholine and dopamine from the rabbit striatum. Its modulation by dopaminergic receptors. J. Neurochem. 41, 94-101.
5. Cubeddu L. X., Hoffmann I. S. and James M. K. (1983) Frequency dependent effects on neuronal uptake inhibitors on the autoreceptor-mediated modulation of dopamine and acetylcholine release from the rabbit striatum. J. Pharmacol. Exp. Ther. 226, 88-94.
6. Damsma G., De Boer P., Westerink B. H. C. and Fibiger H. C. (1990) Dopaminergic regulation of striatal cholinergic interneuroe: An in vivo microdialysis study. Naunyn-Schmiedeberg's Arch. Pharmacol. 342, 523-527.
7. Dewey S. L., Smith G. S., Logan J., Alexoff D., Ding T.-S., King P., Papas N., Brodie J. D. and Ashby C. R. Jr. (1995) Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdyalysis. J. Neurosci. 15, 821-829.
8. Drukarch B., Schepens E., Van der Weel M. J. D., De Boer P., Van Vliet B. J. and Stoof J. C. (1990) Lack of a dopamine antoreceptor selective profile of B-HT 920 in functional in vitro model systems of D2 receptors in rat striatum. Eur. J. Pharmacol. 187, 257-269.
9. Duval F., Mokrani M. C., Macher J. P., Crocq M. A., Oliveria Castro J., Bailey P. and Lataste X. (1993) Neuroendocrine profile of SDZ HDC-912 and OPC-4392, two new atypical antipsychotic drugs, in schizophrenic patients. Psychopharmacology 110, 177-180.
10. Hertting G., Zumstein A., Jackisch R., Hoffman I. and Starke K. (1980) Moderation by endogenous dopamine of the release of acetylcholine in the caudate nucleus of the rabbit. Naunyn-Schmiedeberg's Arch. Pharmacol. 315, 111-117.
11. 2 antagonistic actions. Jpn. J. Pharmacol. 53, 321-529.
12. Hoffmann I. S. and Cubeddu L. X. (1982) Rate and duration of stimulation determines presynaptic effects of haloperidol on dopaminergic neurons. J. Neurochem. 39, 585-588.
13. Kato T., Hirose A., Ohno Y., Shimizu H., Tanaka H. and Nakamura M. (1990) Binding profile of SM-9018, a novel antipsychotic candidate. Jpn. J. Pharmacol. 54, 478-481.
14. Maruoka Y., Ohno Y., Kato T., Hirose A., Tatsuno T. and Nakamura M. (1993) Effects of SM-9018, a potential atypical neuroleptic, on the central monoaminergic system in rats. Jpn. J. Pharmacol. 62, 419-422.
15. McGeer P. L., Grewaal D. S. and McGeer E. G. (1974) Influence of non-cholinergic drugs on rat striatal acetylcholine levels. Brain Res. 80, 211-217.
16. Meltzer H. Y. and Nash J. F. (1991) Effects of antipsychotic drugs on serotonin receptors. Pharmacol. Rev. 43, 587-604.
17. Meltzer L. T., Carrathe B. W., Christoffersen C. L., Corbin A. E., Jaen J. C., Ninteman F. W., Pugsley T. A., Serpa K. A., Shin Y.-H., Whetzel S. Z., Wiley J. N., Wise L. D. and Heffner T. G. (1993) Pharmacological profile of the dopamine partial agonist (±)-PD 128483 and its enantiomers. J. Pharmacol. Exp. Ther. 266, 1177-1189.
18. 2 receptor antagonist, using the mouse pole-test. Pharmacol. Biochem. Behav. 49, 19-23.
19. Ohno Y., Kato T., Okada K., Ishida K. and Nakamura M. (1992) Effect of SM-9018, a new atypical antipsychotic agent, on p-chloroamphetamine-induced hyperthermia in rats. Jpn. J. Pharmacol. 58, (suppl. I), 313P.
20. Plantje J. F., Hansen H. A., Daus F. J. and Stoof J. C. (1984) The effects of SCH 23390, YM 09151-2, (+)-and (-)-3-PPP and some classical neuroleptics on D-1 and D-2 receptors in rat neostriatum in vitro. Eur. J. Pharmacol. 105, 73-84.
21. 2 antagonists modulates the effects of D-2 dopamine receptor blockade. J. Pharmacol. Exp. Ther. 253, 1162-1170.
22. 1 dopamine receptors in dopaminergic control of striatal cholinergic transmission. Life Sci. 31, 2883-2890.
23. Sethy V. H. and van Woert M. H. (1974) Regulation of striatal acetylcholine concentration by dopamine receptors. Nature 251, 529-530.
24. Stoof J. C., Verheijden P. F. H. M. and Leysen J. E. (1987) Stimulation of D2-receptors in rat nucleus accumbens slices inhibits dopamine and acetylcholine release but not cyclic AMP formation. Brain Res. 423, 364-368.
25. Stoof J. C., Drukarch B., de Boer P., Westerink B. H. C. and Groenewegen H. J. (1992) Regulation of the activity of striatal cholinergic neurons by dopamine. Neuroscience 47, 755-770.